Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors.
Jama Oncology
Cobain, Erin F EF; Wu, Yi-Mi YM; Vats, Pankaj P; Chugh, Rashmi R; Worden, Francis F; Smith, David C DC; Schuetze, Scott M SM; Zalupski, Mark M MM; Sahai, Vaibhav V; Alva, Ajjai A; Schott, Anne F AF; Caram, Megan E V MEV; Hayes, Daniel F DF; Stoffel, Elena M EM; Jacobs, Michelle F MF; Kumar-Sinha, Chandan C; Cao, Xuhong X; Wang, Rui R; Lucas, David D; Ning, Yu Y; Rabban, Erica E; Bell, Janice J; Camelo-Piragua, Sandra S; Udager, Aaron M AM; Cieslik, Marcin M; Lonigro, Robert J RJ; Kunju, Lakshmi P LP; Robinson, Dan R DR; Talpaz, Moshe M; Chinnaiyan, Arul M AM
Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer.
Science Translational Medicine
Tie, Jeanne J; Wang, Yuxuan Y; Tomasetti, Cristian C; Li, Lu L; Springer, Simeon S; Kinde, Isaac I; Silliman, Natalie N; Tacey, Mark M; Wong, Hui-Li HL; Christie, Michael M; Kosmider, Suzanne S; Skinner, Iain I; Wong, Rachel R; Steel, Malcolm M; Tran, Ben B; Desai, Jayesh J; Jones, Ian I; Haydon, Andrew A; Hayes, Theresa T; Price, Tim J TJ; Strausberg, Robert L RL; Diaz, Luis A LA; Papadopoulos, Nickolas N; Kinzler, Kenneth W KW; Vogelstein, Bert B; Gibbs, Peter P